Presented on July 1st, 2022.
Each month biotechnology, pharmaceutical and academic partners, large and small, working on treatments and a cure for myotonic dystrophy will sit down with our community to share their progress and answer your questions. Click here to learn more about Avidity Biosciences.
The Avidity Biosciences team presents on their AOC technology, the progress of their AOC 1001 program for DM, and the ongoing MARINATM trial.
- Alissa Peters, Patient Advocacy
- Li Tai, MD. PhD., Clinical Development
- Husam Younis, Pharm.D., Ph.D., Research
- Ben Knisely, B.S., Clinical Operations
- Joe Johnston, Regulatory
- Carolyn Ball, P.E., Manufacturing